CD274 and cancer: Cancer Ther., abstract) and to identify ASPS xenografts as intrinsically overexpressing CD274 (PD-L1), making ASPS a target histology for the evaluation of checkpoint inhibition (C.G. O’Sullivan et al., 2018, Connective Tissue Oncology Society Annual Meeting, conference).